Evidence-based guideline: assessment and management of psychiatric disorders in individuals with MS: report of the Guideline Development Subcommittee of the American Academy of Neurology - Wikidata - wikimedia - TriplyDB

Evidence-based guideline: assessment and management of psychiatric disorders in individuals with MS: report of the Guideline Development Subcommittee of the American Academy of Neurology

Evidence-based guideline: assessment and management of psychiatric disorders in individuals with MS: report of the Guideline Development Subcommittee of the American Academy of Neurology

http://www.wikidata.org/entity/Q24615757

about

Electroconvulsive Therapy in Multiple Sclerosis Effects of music and music therapy on mood in neurological patients The Berlin Treatment Algorithm: recommendations for tailored innovative therapeutic strategies for multiple sclerosis-related fatigue Mental Health Comorbidity in MS: Depression, Anxiety, and Bipolar Disorder.The efficacy of a Mindfulness Based Intervention for depressive symptoms in patients with Multiple Sclerosis and their caregivers: study protocol for a randomized controlled clinical trial Intolerance of Uncertainty: Shaping an Agenda for Research on Coping with Multiple Sclerosis.The assessment of depression in people with multiple sclerosis: a systematic review of psychometric validation studies.Diagnostic accuracy for major depression in multiple sclerosis using self-report questionnaires.Depressive Symptoms Correlate with Disability and Disease Course in Multiple Sclerosis Patients: An Italian Multi-Center Study Using the Beck Depression Inventory.Anxiety, emotional processing and depression in people with multiple sclerosis Exploration of Undertreatment and Patterns of Treatment of Depression in Multiple Sclerosis.Increased incidence of rheumatoid arthritis in multiple sclerosis: A nationwide cohort study Fostering adherence to injectable disease-modifying therapies in multiple sclerosis.The link between multiple sclerosis and depression.Benefits, safety, and prescription of exercise in persons with multiple sclerosis.Benefits of Exercise Training in Multiple Sclerosis.Multiple sclerosis in men: management considerations.Depression in multiple sclerosis.Characterizing the phenotype of multiple sclerosis-associated depression in comparison with idiopathic major depression.Differential diagnosis, discerning depression from cognition.Physical activity and cognitive function in adults with multiple sclerosis: an integrative review.Pros and Cons of Medical Cannabis use by People with Chronic Brain Disorders.The effect of executive function on stress, depression, anxiety, and quality of life in multiple sclerosis.Managing psychological stress in the multiple sclerosis medical visit: Patient perspectives and unmet needs.Psychometric properties and validity of Beck Depression Inventory II in multiple sclerosis.Wellness and multiple sclerosis: The National MS Society establishes a Wellness Research Working Group and research priorities.The determinants of depression in a Romanian cohort of multiple sclerosis patients.Antidepressant activity of fingolimod in mice.Validity of four screening scales for major depression in MS.Cognitive and neuropsychiatric disorders among MS patients from Latin America.Ketamine Therapy for Treatment-resistant Depression in a Patient with Multiple Sclerosis: A Case Report.A systematic review of the effectiveness of self-management interventions in people with multiple sclerosis at improving depression, anxiety and quality of life.The Effectiveness of a Body-Affective Mindfulness Intervention for Multiple Sclerosis Patients with Depressive Symptoms: A Randomized Controlled Clinical Trial.Perspectives from the Patient and the Healthcare Professional in Multiple Sclerosis: Social Media and Patient Education.Online tools for individuals with depression and neurologic conditions: A scoping review.Depression in epilepsy, migraine, and multiple sclerosis: Epidemiology and how to screen for it.A single-group pilot feasibility study of cognitive behavioural therapy in people with multiple sclerosis with depressive symptoms.Internet-based treatment for depression in multiple sclerosis: A randomized controlled trial.Treatment of mood disorders in multiple sclerosis.Target Coping Strategies for Interventions Aimed at Maximizing Psychosocial Adjustment in People with Multiple Sclerosis.

P2860

Q26782370-E7E81AE3-B397-4CA0-AC4C-8217A36AC219 Q26821809-36E322D9-E22D-4E4B-8098-DAC894C55468 Q28073849-AB746749-1241-4FC2-9676-73EDEDCC6FB4 Q30241221-CE07C46C-6F6F-473B-8B65-8A09E3BB9026 Q35891823-54BAA264-86B8-46D3-BF74-79A8ABD17F02 Q35974817-98B7486D-362E-4B66-9084-3C6BB05064DC Q36095314-A7E32ECB-F7E4-40C3-A2EC-B24DDE669CF4 Q36109858-6ECD7428-8F75-4CF8-AA70-56EC5E46844F Q36134388-5F00CD5A-A6ED-4884-9CF5-A90686F4C8E5 Q36288921-6896DC7F-FF57-428D-AA02-F19033B512F7 Q36358378-01F7CCBC-5387-4D6D-9FA8-AD50BB65FCD0 Q37077947-2A2097B4-9C25-465C-AB41-76A7EF87798C Q38238548-86C638A1-CC4F-44FF-8BFA-F29E348BEA0B Q38238940-1F9D3895-8ECC-499C-8B62-A902E67A3115 Q38270008-A0F7F75C-7373-4A59-8EFD-922CA7F044D5 Q38557086-69B65B54-37DE-4E0A-A534-4FEC0C5E2C41 Q38685411-0D9E1F49-473B-4524-803B-66052765A2CF Q38691568-9977C2E6-1F4B-4444-9B5B-877E690CB943 Q38922838-50A68C3C-A538-4489-9B68-1648EC66EDB5 Q38942624-8D5861AA-CEE1-4307-B278-5DF38F6587C7 Q38986441-2CBE6C42-B90D-4966-9667-1947B275D24A Q38996589-60438CDA-934B-4BF4-8A92-E1881B4CF012 Q39002824-9F459265-49F9-4B9C-BB33-AF56B909CD58 Q39070531-FA9FFC07-4577-4361-891A-57D95D717C9D Q40091385-E77B9896-FD2D-4DA0-AEA5-320E6A34DCEB Q40383948-7DB4016F-F6E4-47FA-B5BD-4C7AE7A9860F Q41255810-1AF6FAE3-C36A-4E14-9080-4FBBDFC6EE4A Q41359968-099BB175-4413-46B0-8555-01C724BF4D5F Q41589787-32FABA1A-7D6F-4890-B702-F98453442A5B Q41948827-BA58299A-39A6-4F68-BCCD-FFF8B4C5C013 Q42293271-8F6CFBD7-030A-4918-B01D-97BF4937FF6C Q42705259-98F1B3FD-157C-43DB-8249-63C28A04C3C4 Q47165616-F588588B-816F-40D0-B1C5-0E3F4956E309 Q47574615-2FF8CAEF-C8BC-4CC9-82F2-E5A93E4C5677 Q47693150-0D526439-C7A1-4704-88D1-768F25F8EA79 Q47693163-2025D179-A769-40C8-8455-74F6A08DC101 Q47918997-6FB78208-822A-4DBE-892D-E6117C91D01A Q47926747-B406D359-3F1F-48DF-B0CB-D9313256563E Q48175352-98B69DE1-DE21-4305-9B42-0B7D27FB710D Q55046085-F718119A-65CA-4CDF-83D1-D5807A46D310

P2860

Evidence-based guideline: assessment and management of psychiatric disorders in individuals with MS: report of the Guideline Development Subcommittee of the American Academy of Neurology

http://www.wikidata.org/entity/Q24615757

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Evidence-based guideline: asse ...... American Academy of Neurology

@ast

Evidence-based guideline: asse ...... American Academy of Neurology

@en

Evidence-based guideline: asse ...... American Academy of Neurology

@nl

type

label

Evidence-based guideline: asse ...... American Academy of Neurology

@ast

Evidence-based guideline: asse ...... American Academy of Neurology

@en

Evidence-based guideline: asse ...... American Academy of Neurology

@nl

prefLabel

Evidence-based guideline: asse ...... American Academy of Neurology

@ast

Evidence-based guideline: asse ...... American Academy of Neurology

@en

Evidence-based guideline: asse ...... American Academy of Neurology

@nl

P1433

Q24615757-FE732111-3B03-458E-B48B-7CA694B366C3

P1476

Q24615757-A6B2BAA2-D579-4948-9586-E368DC966E92

P2093

Q24615757-0BBE32D7-F05D-4554-9323-EA65B0508708

Q24615757-3623BAEA-A843-4937-8DDD-8DEAFAFCDF3E

Q24615757-80532971-8564-4467-939D-33A084A22FBB

Q24615757-A55CBBDF-363F-46B8-A5B4-C3DE3F6CB1E6

Q24615757-AEF457E9-8EA4-4F7D-BBD4-495BB0C1B1FA

Q24615757-B6A3CA11-B5D8-4EF8-88B5-934BEAD6639E

Q24615757-F82196AA-7BAC-4429-9FC6-6AEE9E189381

Q24615757-FF92AD5D-61E2-4247-B9F8-1DF7452F2D9D

P2860

Q24615757-0209177A-8C91-4F63-A11B-232FE61AB348

Q24615757-154C0532-43D7-4C17-BF78-7CE8E2AA9CA9

Q24615757-20467E41-5652-4055-B170-DA83E92DB637

Q24615757-2B899174-7D4B-4653-9F9E-070B7245478B

Q24615757-391A3B1A-754F-448C-B3B8-D5A009070268

Q24615757-40DED8F1-4D9D-4BDE-9ADB-E841EFFEE816

Q24615757-463C2B66-63E5-4562-945F-CCB4321C449B

Q24615757-4CFD201C-C4DF-408A-AED3-BA80711B2A70

Q24615757-4FF3C3AB-0598-473B-9846-3579EF68981D

Q24615757-51597C3A-66F4-468A-B449-D8E4E56E2856

P304

Q24615757-45E22825-F9AE-4B93-8C41-3DB9615CF64B

P31

Q24615757-AB1BFBFB-A209-4543-B277-C2F4E698428E

P3181

Q24615757-E50AD7DD-EF6A-4E16-9F55-D6181A222FD5

P356

Q24615757-369AC8F0-8D5E-42D8-B541-4761CD2AA6B6

P407

Q24615757-D96AE139-56FE-483F-A204-3D52AD02C9D7

P433

Q24615757-3CB0E992-5A47-4875-91A8-4B5D21252C93

P478

Q24615757-3F4D5CB6-477F-4BBC-A7EC-C4CC27615BA9

P50

Q24615757-19D7F299-AB9C-4450-BF43-4BED948897B0

Q24615757-2E9418E8-5410-45F5-B6F1-012A653F45B7

P577

Q24615757-E8E2A826-BB66-4ADB-8A4A-2B92B1DE84B1

P5875

Q24615757-28FC10FD-A239-43AF-AE03-7522C484C6C5

P698

Q24615757-55393B4F-B899-4A74-904F-B92E4E3A945C

P932

Q24615757-175E4F05-796B-4AD7-8299-205465A179AC

P3181

P356

WNL.0000000000000013

P1433

P1476

Evidence-based guideline: asse ...... American Academy of Neurology

@en

P2093

Anthony Feinstein

http://www.w3.org/2001/XMLSchema#string

Christopher Bever

http://www.w3.org/2001/XMLSchema#string

Deborah Miller

http://www.w3.org/2001/XMLSchema#string

Gary S Gronseth

http://www.w3.org/2001/XMLSchema#string

Pushpa Narayanaswami

http://www.w3.org/2001/XMLSchema#string

Randolph B Schiffer

http://www.w3.org/2001/XMLSchema#string

Rosalind C Kalb

http://www.w3.org/2001/XMLSchema#string

Sarah L Minden

http://www.w3.org/2001/XMLSchema#string

P2860

Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication

Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication

An Inventory for Measuring Depression

Major depression in multiple sclerosis: a population-based perspective

Prevalence and neurobehavioral correlates of pathological laughing and crying in multiple sclerosis

Depression and multiple sclerosis

Cause of death in patients attending multiple sclerosis clinics

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)

Multiple sclerosis, disease modifying treatments and depression: a critical methodological review.

Pseudobulbar affect: an under-recognized and under-treated neurological disorder.

P304

174-81

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1347328

http://www.w3.org/2001/XMLSchema#string

P356

10.1212/WNL.0000000000000013

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

82

http://www.w3.org/2001/XMLSchema#string

P50

Scott B. Patten

P577

2014-01-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259492197

http://www.w3.org/2001/XMLSchema#string

P698

24376275

http://www.w3.org/2001/XMLSchema#string

P932

3897434

http://www.w3.org/2001/XMLSchema#string